动物命名测试:评估肝性脑病的简便工具
研究纳入208名健康对照、40名炎症性肠病对照和327例连续肝硬化患者,评估动物命名测试(ANT1)对肝性脑病(HE)的评估价值。采用年龄和教育调整后的简化ANT1(S-ANT1),S-ANT1<10为异常;S-ANT1及其三级评分与心理测量HE评分和脑电图相关,并对1年内显性HE和死亡有预后价值。结论:S-ANT1是评估HE的简便有用指标。
要点
- 健康对照中ANT1受教育程度低(<8年)和高龄(>80岁)影响(P<0.001)。
- S-ANT1<10为异常,15个动物对区分无损伤与MHE/1级HE辨别最佳。
- S-ANT1及其三级评分与心理测量HE评分(P<0.0001)和脑电图(P=0.007)相关。
核心结论
- S-ANT1是评估肝性脑病的简便易行指标。
研究设计与样本
- 研究纳入208名健康对照、40名炎症性肠病对照和327例连续肝硬化患者,均接受ANT1测试。
- 患者通过心理测量HE评分筛查MHE,其中146例接受脑电图评估;202例患者随访显性HE发生和死亡。
主要发现
- 健康对照中ANT1受教育程度低(<8年)和高龄(>80岁)影响(P<0.001)。
- 采用年龄和教育调整程序获得简化ANT1(S-ANT1),S-ANT1<10为异常。
- 169例患者被认为无损伤,32例为HE≥2级,126例为MHE/1级HE;该组S-ANT1低于无损伤患者(12±0.4 vs 16±0.7,P<0.001),高于HE≥2级患者(4±0.9)。
- 1级HE患者S-ANT1低于MHE患者。
- 受试者工作特征分析(Youden指数)显示,15个动物对区分无损伤与MHE/1级HE患者辨别最佳;据此获得三级评分(S-ANT1≥15为0分,10≤S-ANT1<15为1分,S-ANT1<10为2分)。
关键数值与推荐
- S-ANT1<10为异常。
- 三级评分:S-ANT1≥15为0分,10≤S-ANT1<15为1分,S-ANT1<10为2分。
- 15个动物对区分无损伤与MHE/1级HE患者辨别最佳(Youden指数)。
临床怎么用
- S-ANT1是评估肝性脑病的简便易行指标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Screening for hepatic encephalopathy (HE) that does not cause obvious disorientation or asterixis (minimal HE [MHE]/grade 1 HE) is important. We examined if the animal naming test (ANT1 ) (maximum number of animals listed in 1 minute) is useful in this context. In total, 208 healthy controls, 40 controls with inflammatory bowel disease, and 327 consecutive patients with cirrhosis underwent the ANT1 . Patients were tested for MHE by the psychometric HE score, and 146 were assessed by electroencephalography; 202 patients were followed up regarding the occurrence of overt HE and death. In the healthy controls, ANT1 was influenced by limited education (<8 years) and advanced age (>80 years, P < 0.001). Using an age and education adjusting procedure, the simplified ANT1 (S-ANT1 ) was obtained. An S-ANT1 of <10 animals was abnormal. Of the patients, 169 were considered unimpaired, 32 as having HE ≥grade 2, and 126 as having MHE/grade 1 HE. This group had lower S-ANT1 than unimpaired patients (12 ± 0.4 versus 16 ± 0.7, P < 0.001) and higher S-ANT1 than those with HE ≥grade 2 (4 ± 0.9). In grade 1 HE the S-ANT1 was lower than in MHE. Following receiver operating characteristic analysis (Youden's index), 15 animals produced the best discrimination between unimpaired and MHE/grade 1 HE patients. Thus, a three-level score (0 for S-ANT1 ≥15, 1 for 10 ≤ S-ANT1 < 15, 2 for S-ANT1 <10) was obtained. This score was correlated both to the psychometric HE score (P < 0.0001) and to electroencephalography (P = 0.007). By sample random split validation, both S-ANT1 and its three-level score showed prognostic value regarding the 1-year risk of overt HE and death. No inflammatory bowel disease control had S-ANT <15. CONCLUSION: The S-ANT1 is an easily obtainable measure useful for the assessment of HE. (Hepatology 2017;66:198-208).
引用
- Campagna F, Montagnese S, Ridola L, et al. The animal naming test: An easy tool for the assessment of hepatic encephalopathy. Hepatology. 2017. PMID: 28271528. doi:10.1002/hep.29146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。